Crossmark

Biological and clinical impact of central nervous system hemangioblastomas in Chinese patients with von Hippel-Lindau disease: implications for treatment

Crossref DOI link: https://doi.org/10.1186/s13053-020-00153-y

Published Online: 2020-10-22

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Zhen

Li, Liang https://orcid.org/0000-0003-4075-1186
Yi, Zhiqiang

Duan, Hongzhou

Lu, Runchun

Li, Chunwei

Li, Lei

Gong, Kan
Funding

Funding for this research was provided by:

Peking University First Hospital Cross Clinical Study Foundation;Youth Clinical Research Project of Peking University First Hospital (2019CR02)
License Information

Text and Data Mining valid from 2020-10-22

Version of Record valid from 2020-10-22
More Information

Article History

Received: 8 January 2020

Accepted: 19 October 2020

First Online: 22 October 2020

Ethics approval and consent to participate

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

: Not applicable.

: The authors certify that there is no conflict of interest with any individual/organization for the present work.

Document is current

Any future updates will be listed below